These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 26402737)
1. Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection. Costa RF; Longatto-Filho A; Pinheiro C; Zeferino LC; Fregnani JH PLoS One; 2015; 10(9):e0138945. PubMed ID: 26402737 [TBL] [Abstract][Full Text] [Related]
2. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index. Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602 [TBL] [Abstract][Full Text] [Related]
3. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013. Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG BMC Cancer; 2018 Feb; 18(1):126. PubMed ID: 29394915 [TBL] [Abstract][Full Text] [Related]
4. [Cervical cancer screening in the State of Maranhão, Brazil]. Silva DS; Silva AM; Brito LM; Gomes SR; Nascimento Mdo D; Chein MB Cien Saude Colet; 2014 Apr; 19(4):1163-70. PubMed ID: 24820599 [TBL] [Abstract][Full Text] [Related]
5. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test. Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151 [TBL] [Abstract][Full Text] [Related]
6. Patterns of cervical cytological abnormalities according to the Human Development Index in the northeast region of Brazil. Pinho-França JR; Chein MBDC; Thuler LCS BMC Womens Health; 2016 Aug; 16():54. PubMed ID: 27516107 [TBL] [Abstract][Full Text] [Related]
7. Quality Indicators of Cervical Cytopathology Tests in the Public Service in Minas Gerais, Brazil. Tobias AH; Amaral RG; Diniz EM; Carneiro CM Rev Bras Ginecol Obstet; 2016 Feb; 38(2):65-70. PubMed ID: 26883863 [TBL] [Abstract][Full Text] [Related]
8. Internal quality control indicators of cervical cytopathology exams performed in laboratories monitored by the External Quality Control Laboratory. Ázara CZ; Manrique EJ; Tavares SB; de Souza NL; Amaral RG Rev Bras Ginecol Obstet; 2014 Sep; 36(9):398-403. PubMed ID: 25272360 [TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011). Vīberga I; Poljak M Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):27-30. PubMed ID: 23674182 [TBL] [Abstract][Full Text] [Related]
10. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme. Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988 [TBL] [Abstract][Full Text] [Related]
11. [Cervical cancer screening in Hungary--epidemiologic, historical and methodologic aspects]. Langmár Z; Németh M; Kornya L Orv Hetil; 2011 Dec; 152(51):2063-6. PubMed ID: 22130204 [TBL] [Abstract][Full Text] [Related]
12. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic. Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155 [TBL] [Abstract][Full Text] [Related]
13. Could alarmingly high rates of negative diagnoses in remote rural areas be minimized with liquid-based cytology? Preliminary results from the RODEO Study Team. Fregnani JH; Scapulatempo C; Haikel RL; Saccheto T; Campacci N; Mauad EC; Longatto-Filho A; Acta Cytol; 2013; 57(1):69-74. PubMed ID: 23221353 [TBL] [Abstract][Full Text] [Related]
14. Is a liquid-based cytology more sensitive than a conventional Pap smear? Sigurdsson K Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613 [TBL] [Abstract][Full Text] [Related]
15. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women. Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021 [TBL] [Abstract][Full Text] [Related]
16. [Why does the prevalence of cytopathological results of cervical cancer screening can vary significantly between two regions of Brazil?]. Discacciati MG; Barboza BM; Zeferino LC Rev Bras Ginecol Obstet; 2014 May; 36(5):192-7. PubMed ID: 25003469 [TBL] [Abstract][Full Text] [Related]
17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Liao SY; Stanbridge EJ Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360 [TBL] [Abstract][Full Text] [Related]
18. Is there a role for cervicography in the detection of premalignant lesions of the uterine cervix?: a Brazilian experience. Gasperin P; Francisco JA; Tizzot EL; Curcio L; Couto Filho Jd; Moreira PR; Pascotini CM; de Azevedo EM; Coibion M; Budel VM; de Carvalho NS J Low Genit Tract Dis; 2012 Oct; 16(4):387-93. PubMed ID: 22659773 [TBL] [Abstract][Full Text] [Related]
19. [Community-based cervical cancer screening in seven townships in Taiwan]. Chen CJ; You SL; Pwu RF; Wang LY; Lin YP; Hsi GC; Hsi MS; Ho HC; Lee CT; Lin CG J Formos Med Assoc; 1995 Dec; 94 Suppl 2():S103-11. PubMed ID: 8672938 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix]. Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]